{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:05:58Z","timestamp":1791137158992,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870825, 82071194"],"award-info":[{"award-number":["81870825, 82071194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Brain Initiative from Beijing Municipal Science & Technology Commission","award":["Z201100005520016"],"award-info":[{"award-number":["Z201100005520016"]}]},{"name":"Beijing Municipal Natural Science Foundation","award":["7202061"],"award-info":[{"award-number":["7202061"]}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2022-2-2017"],"award-info":[{"award-number":["2022-2-2017"]}]},{"name":"STI2030-Major Projects","award":["2022ZD0211600, 2022ZD0211605"],"award-info":[{"award-number":["2022ZD0211600, 2022ZD0211605"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Complement dysregulation is increasingly recognized in Alzheimer\u2019s disease (AD). However, the temporal profile of complement alterations preceding AD onset and their distinction from age-related immune changes remain poorly defined. Clarifying these dynamics could provide insights into AD pathogenesis and identify systemic factors that predict disease onset and progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a study involving two cohorts: a longitudinal cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009235; all cognitively normal at baseline) and a cross-sectional cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009323; including 53 with AD, 54 with vascular dementia, 51 with Parkinson\u2019s disease dementia, 56 with behavioral variant frontotemporal dementia, and 52 with dementia with Lewy bodies). Plasma levels of 14 complement factors were assessed every 2 years over a 10-year follow-up period in the longitudinal cohort and once in the cross-sectional cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the longitudinal cohort, aging was accompanied by gradual reductions in C4, C4b, Factor I, and Properdin and by increases in Factor D. These changes were more pronounced in individuals who subsequently developed AD. Importantly, this pattern of complement alterations was detectable during the preclinical and clinical phases of AD but was not observed in other dementias. In the cross-sectional cohort, the same complement profile was specific to AD and distinguished it from other dementia subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The results of this study indicate an AD-specific peripheral complement signature associated with disease development, highlighting complement factors as critical immune mediators that link aging and AD. This signature implicates complement factors as promising systemic markers for early detection and potential therapeutic targeting in preclinical AD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-026-00927-3","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T15:53:52Z","timestamp":1768233232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systemic complement factors in aging, Alzheimer\u2019s disease and other dementias: a longitudinal study over 10 years"],"prefix":"10.1186","volume":"21","author":[{"given":"Xiaofeng","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiyue","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbiao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yana","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QianQian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"927_CR1","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1016\/S2468-2667(20)30185-7","volume":"5","author":"L Jia","year":"2020","unstructured":"Jia L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in china: a cross-sectional study. Lancet Public Health. 2020;5:e661\u201371. https:\/\/doi.org\/10.1016\/S2468-2667(20)30185-7.","journal-title":"Lancet Public Health"},{"key":"927_CR2","unstructured":"Gauthier S, Webster C, Servaes S, Morais JA, Rosa-Neto P. World Alzheimer Report 2022: Life after diagnosis: Navigating treatment, care and support. Alzheimer\u2019s Disease International; 2022. p. 1\u2013414."},{"key":"927_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/brain\/awae230","volume":"148","author":"H Cai","year":"2025","unstructured":"Cai H, et al. Systemic inflammatory markers in ageing, alzheimer\u2019s disease and other dementias. Brain. 2025;148:480\u201392. https:\/\/doi.org\/10.1093\/brain\/awae230.","journal-title":"Brain"},{"key":"927_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1146\/annurev-immunol-101921-035222","volume":"42","author":"A Mary","year":"2024","unstructured":"Mary A, Mancuso R, Heneka MT. Immune activation in alzheimer disease. Annu Rev Immunol. 2024;42:585\u2013613. https:\/\/doi.org\/10.1146\/annurev-immunol-101921-035222.","journal-title":"Annu Rev Immunol"},{"key":"927_CR5","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol. 2013;190:3831\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1203487.","journal-title":"J Immunol"},{"key":"927_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tins.2018.03.009","volume":"41","author":"LG Coulthard","year":"2018","unstructured":"Coulthard LG, Hawksworth OA, Woodruff TM, Complement. The emerging architect of the developing brain. Trends Neurosci. 2018;41:373\u201384. https:\/\/doi.org\/10.1016\/j.tins.2018.03.009.","journal-title":"Trends Neurosci"},{"key":"927_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/BF00687336","volume":"63","author":"T Ishii","year":"1984","unstructured":"Ishii T, Haga S. Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol. 1984;63:296\u2013300. https:\/\/doi.org\/10.1007\/BF00687336.","journal-title":"Acta Neuropathol"},{"key":"927_CR8","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","volume":"89","author":"J Rogers","year":"1992","unstructured":"Rogers J, et al. Complement activation by beta-amyloid in alzheimer disease. Proc Natl Acad Sci U S A. 1992;89:10016\u201320. https:\/\/doi.org\/10.1073\/pnas.89.21.10016.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"927_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/BF00192116","volume":"426","author":"R Veerhuis","year":"1995","unstructured":"Veerhuis R, et al. Complement activation in amyloid plaques in alzheimer\u2019s disease brains does not proceed further than C3. Virchows Arch. 1995;426:603\u201310. https:\/\/doi.org\/10.1007\/BF00192116.","journal-title":"Virchows Arch"},{"key":"927_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12974-023-02850-6","volume":"20","author":"A Veteleanu","year":"2023","unstructured":"Veteleanu A, et al. Alzheimer\u2019s disease-associated complement gene variants influence plasma complement protein levels. J Neuroinflammation. 2023;20:169. https:\/\/doi.org\/10.1186\/s12974-023-02850-6.","journal-title":"J Neuroinflammation"},{"key":"927_CR11","doi-asserted-by":"publisher","first-page":"10676","DOI":"10.18632\/aging.103286","volume":"12","author":"W Cao","year":"2020","unstructured":"Cao W, et al. Modelling biological age based on plasma peptides in Han Chinese adults. Aging. 2020;12:10676\u201386. https:\/\/doi.org\/10.18632\/aging.103286.","journal-title":"Aging"},{"key":"927_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.arr.2018.07.004","volume":"47","author":"AL Cardoso","year":"2018","unstructured":"Cardoso AL, et al. Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases. Ageing Res Rev. 2018;47:214\u201377. https:\/\/doi.org\/10.1016\/j.arr.2018.07.004.","journal-title":"Ageing Res Rev"},{"key":"927_CR13","doi-asserted-by":"publisher","unstructured":"Hsu AY, et al. Neutrophil-derived vesicles control complement activation to facilitate inflammation resolution. Cell. 2025;188:1623\u20131641.e6. https:\/\/doi.org\/10.1016\/j.cell.2025.01.021","DOI":"10.1016\/j.cell.2025.01.021"},{"key":"927_CR14","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","volume":"461","author":"RJ Perrin","year":"2009","unstructured":"Perrin RJ, Fagan AM, Holtzman DM. Multimodal techniques for diagnosis and prognosis of alzheimer\u2019s disease. Nature. 2009;461:916\u201322. https:\/\/doi.org\/10.1038\/nature08538.","journal-title":"Nature"},{"key":"927_CR15","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.jalz.2018.07.223","volume":"14","author":"KL Rasmussen","year":"2018","unstructured":"Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF. An updated alzheimer hypothesis: complement C3 and risk of alzheimer\u2019s disease-A cohort study of 95,442 individuals. Alzheimers Dement. 2018;14:1589\u2013601. https:\/\/doi.org\/10.1016\/j.jalz.2018.07.223.","journal-title":"Alzheimers Dement"},{"key":"927_CR16","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1093\/brain\/awl279","volume":"129","author":"A Hye","year":"2006","unstructured":"Hye A, et al. Proteome-based plasma biomarkers for alzheimer\u2019s disease. Brain. 2006;129:3042\u201350. https:\/\/doi.org\/10.1093\/brain\/awl279.","journal-title":"Brain"},{"key":"927_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13195-023-01377-5","volume":"16","author":"M Li","year":"2024","unstructured":"Li M, et al. Associations of cerebrospinal fluid complement proteins with alzheimer\u2019s pathology, cognition, and brain structure in non-dementia elderly. Alzheimers Res Ther. 2024;16:12. https:\/\/doi.org\/10.1186\/s13195-023-01377-5.","journal-title":"Alzheimers Res Ther"},{"key":"927_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/JAD-230513","volume":"96","author":"J Zhou","year":"2023","unstructured":"Zhou J, et al. Cerebrospinal fluid complement 4 levels were associated with alzheimer\u2019s disease pathology and cognition in Non-Demented elderly. J Alzheimers Dis. 2023;96:1071\u201381. https:\/\/doi.org\/10.3233\/JAD-230513.","journal-title":"J Alzheimers Dis"},{"key":"927_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/01.wad.0000165506.60370.94","volume":"19","author":"H Zanjani","year":"2005","unstructured":"Zanjani H, et al. Complement activation in very early alzheimer disease. Alzheimer Dis Assoc Disord. 2005;19:55\u201366. https:\/\/doi.org\/10.1097\/01.wad.0000165506.60370.94.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"927_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","volume":"15","author":"AR Morgan","year":"2019","unstructured":"Morgan AR, et al. Inflammatory biomarkers in alzheimer\u2019s disease plasma. Alzheimers Dement. 2019;15:776\u201387. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.007.","journal-title":"Alzheimers Dement"},{"key":"927_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.biopsych.2021.06.021","volume":"90","author":"T Da Silva","year":"2021","unstructured":"Da Silva T, et al. Genetically predicted brain C4A expression is associated with TSPO and hippocampal morphology. Biol Psychiatry. 2021;90:652\u201360. https:\/\/doi.org\/10.1016\/j.biopsych.2021.06.021.","journal-title":"Biol Psychiatry"},{"key":"927_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177\u201383. https:\/\/doi.org\/10.1038\/nature16549.","journal-title":"Nature"},{"key":"927_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41593-020-00763-8","volume":"24","author":"M Yilmaz","year":"2021","unstructured":"Yilmaz M, et al. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nat Neurosci. 2021;24:214\u201324. https:\/\/doi.org\/10.1038\/s41593-020-00763-8.","journal-title":"Nat Neurosci"},{"key":"927_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jaci.2025.03.013","volume":"156","author":"R Moreno","year":"2025","unstructured":"Moreno R, Broderick L. Complement factor I deficiency: diverse phenotypes. J Allergy Clin Immunol. 2025;156:305\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2025.03.013.","journal-title":"J Allergy Clin Immunol"},{"key":"927_CR25","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.molimm.2011.04.004","volume":"48","author":"SC Nilsson","year":"2011","unstructured":"Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM. Complement factor I in health and disease. Mol Immunol. 2011;48:1611\u201320. https:\/\/doi.org\/10.1016\/j.molimm.2011.04.004.","journal-title":"Mol Immunol"},{"key":"927_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0169-328x(00)00149-2","volume":"81","author":"R Strohmeyer","year":"2000","unstructured":"Strohmeyer R, Shen Y, Rogers J. Detection of complement alternative pathway mRNA and proteins in the alzheimer\u2019s disease brain. Brain Res Mol Brain Res. 2000;81:7\u201318. https:\/\/doi.org\/10.1016\/s0169-328x(00)00149-2.","journal-title":"Brain Res Mol Brain Res"},{"key":"927_CR27","doi-asserted-by":"publisher","first-page":"e70017","DOI":"10.1111\/bpa.70017","volume":"35","author":"J Nimmo","year":"2025","unstructured":"Nimmo J, Keat S, De Muynck L, Morgan BP. Complement dysregulation in human tauopathies. Brain Pathol. 2025;35:e70017. https:\/\/doi.org\/10.1111\/bpa.70017.","journal-title":"Brain Pathol"},{"key":"927_CR28","doi-asserted-by":"publisher","first-page":"e28527","DOI":"10.1371\/journal.pone.0028527","volume":"6","author":"M Thambisetty","year":"2011","unstructured":"Thambisetty M, et al. Plasma biomarkers of brain atrophy in alzheimer\u2019s disease. PLoS ONE. 2011;6:e28527. https:\/\/doi.org\/10.1371\/journal.pone.0028527.","journal-title":"PLoS ONE"},{"key":"927_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10875-012-9767-z","volume":"33","author":"L Broderick","year":"2013","unstructured":"Broderick L, et al. Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis. J Clin Immunol. 2013;33:162\u201371. https:\/\/doi.org\/10.1007\/s10875-012-9767-z.","journal-title":"J Clin Immunol"},{"key":"927_CR30","doi-asserted-by":"publisher","first-page":"e200475","DOI":"10.1212\/NXI.0000000000200475","volume":"12","author":"T Hu","year":"2025","unstructured":"Hu T, et al. Complement factor I deficiency with acute hemorrhagic leukoencephalitis and longitudinally extensive transverse myelitis: A case report. Neurol Neuroimmunol Neuroinflamm. 2025;12:e200475. https:\/\/doi.org\/10.1212\/NXI.0000000000200475.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"927_CR31","doi-asserted-by":"publisher","first-page":"e200191","DOI":"10.1212\/NXI.0000000000200191","volume":"11","author":"V Massey","year":"2024","unstructured":"Massey V, et al. CNS inflammation as the first sign of complement factor I deficiency: A severe myelitis treated with intense immunotherapy and Eculizumab. Neurol Neuroimmunol Neuroinflamm. 2024;11:e200191. https:\/\/doi.org\/10.1212\/NXI.0000000000200191.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"927_CR32","doi-asserted-by":"publisher","unstructured":"Rolfes M, et al. Complement factor I gene variant as a treatable cause of recurrent aseptic neutrophilic meningitis: a case report. Neurol Neuroimmunol Neuroinflamm. 2023;10. https:\/\/doi.org\/10.1212\/NXI.0000000000200121.","DOI":"10.1212\/NXI.0000000000200121"},{"key":"927_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molimm.2018.05.018","volume":"102","author":"JY Chen","year":"2018","unstructured":"Chen JY, Cortes C, Ferreira VP, Properdin. A multifaceted molecule involved in inflammation and diseases. Mol Immunol. 2018;102:58\u201372. https:\/\/doi.org\/10.1016\/j.molimm.2018.05.018.","journal-title":"Mol Immunol"},{"key":"927_CR34","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1038\/s41598-022-09407-2","volume":"12","author":"A Shahraz","year":"2022","unstructured":"Shahraz A, et al. Low molecular weight polysialic acid binds to Properdin and reduces the activity of the alternative complement pathway. Sci Rep. 2022;12:5818. https:\/\/doi.org\/10.1038\/s41598-022-09407-2.","journal-title":"Sci Rep"},{"key":"927_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s12974-023-02946-z","volume":"20","author":"PY Liu","year":"2023","unstructured":"Liu PY, et al. Infiltrating myeloid cell-derived Properdin markedly promotes microglia-mediated neuroinflammation after ischemic stroke. J Neuroinflammation. 2023;20:260. https:\/\/doi.org\/10.1186\/s12974-023-02946-z.","journal-title":"J Neuroinflammation"},{"key":"927_CR36","doi-asserted-by":"publisher","first-page":"108588","DOI":"10.1016\/j.compbiomed.2024.108588","volume":"176","author":"A Gomez-Pascual","year":"2024","unstructured":"Gomez-Pascual A, et al. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to alzheimer\u2019s disease. Comput Biol Med. 2024;176:108588. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108588.","journal-title":"Comput Biol Med"},{"key":"927_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/s0140-6736(89)90712-5","volume":"2","author":"CA Fijen","year":"1989","unstructured":"Fijen CA, Kuijper EJ, Hannema AJ, Sjoholm AG, van Putten JP. Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet. 1989;2:585\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(89)90712-5.","journal-title":"Lancet"},{"key":"927_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-2094-8-4","volume":"8","author":"MI Fonseca","year":"2011","unstructured":"Fonseca MI, et al. Contribution of complement activation pathways to neuropathology differs among mouse models of alzheimer\u2019s disease. J Neuroinflammation. 2011;8:4. https:\/\/doi.org\/10.1186\/1742-2094-8-4.","journal-title":"J Neuroinflammation"},{"key":"927_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cell.2014.06.005","volume":"158","author":"JC Lo","year":"2014","unstructured":"Lo JC, et al. Adipsin is an adipokine that improves beta cell function in diabetes. Cell. 2014;158:41\u201353. https:\/\/doi.org\/10.1016\/j.cell.2014.06.005.","journal-title":"Cell"},{"key":"927_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1126\/science.3299705","volume":"237","author":"KS Cook","year":"1987","unstructured":"Cook KS, et al. Adipsin: a Circulating Serine protease homolog secreted by adipose tissue and sciatic nerve. Science. 1987;237:402\u20135. https:\/\/doi.org\/10.1126\/science.3299705.","journal-title":"Science"},{"key":"927_CR41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12902-019-0431-y","volume":"19","author":"D Guo","year":"2019","unstructured":"Guo D, et al. Association between plasma adipsin level and mild cognitive impairment in Chinese patients with type 2 diabetes: a cross-sectional study. BMC Endocr Disord. 2019;19:108. https:\/\/doi.org\/10.1186\/s12902-019-0431-y.","journal-title":"BMC Endocr Disord"},{"key":"927_CR42","doi-asserted-by":"publisher","first-page":"107270","DOI":"10.1016\/j.vph.2023.107270","volume":"154","author":"A Dare","year":"2024","unstructured":"Dare A, Chen SY. Adipsin in the pathogenesis of cardiovascular diseases. Vascul Pharmacol. 2024;154:107270. https:\/\/doi.org\/10.1016\/j.vph.2023.107270.","journal-title":"Vascul Pharmacol"},{"key":"927_CR43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cen.12856","volume":"84","author":"A Schmid","year":"2016","unstructured":"Schmid A, et al. Quantification and regulation of adipsin in human cerebrospinal fluid (CSF). Clin Endocrinol (Oxf). 2016;84:194\u2013202. https:\/\/doi.org\/10.1111\/cen.12856.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"927_CR44","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, et al. The diagnosis of dementia due to alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimers Dement"},{"key":"927_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-141725","volume":"44","author":"JL Seeburger","year":"2015","unstructured":"Seeburger JL, et al. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed alzheimer\u2019s disease from other dementias and healthy controls in the OPTIMA cohort. J Alzheimers Dis. 2015;44:525\u201339. https:\/\/doi.org\/10.3233\/JAD-141725.","journal-title":"J Alzheimers Dis"},{"key":"927_CR46","doi-asserted-by":"publisher","unstructured":"Roman GC, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250\u2013260. https:\/\/doi.org\/10.1212\/wnl.43.2.250.","DOI":"10.1212\/wnl.43.2.250"},{"issue":"2","key":"927_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ana.21455","volume":"64","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Emre M, Dubois B. Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol. 2008;64(2):81\u201392. https:\/\/doi.org\/10.1002\/ana.21455.","journal-title":"Ann Neurol"},{"key":"927_CR48","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456\u201377. https:\/\/doi.org\/10.1093\/brain\/awr179.","journal-title":"Brain"},{"key":"927_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, et al. Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB consortium. Neurology. 2017;89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058.","journal-title":"Neurology"},{"key":"927_CR50","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","volume":"73","author":"CE Teunissen","year":"2009","unstructured":"Teunissen CE, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73:1914\u201322. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c47cc2.","journal-title":"Neurology"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-026-00927-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00927-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-026-00927-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:36:39Z","timestamp":1770644199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13024-026-00927-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["927"],"URL":"https:\/\/doi.org\/10.1186\/s13024-026-00927-3","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were conducted in accordance with the Declaration of Helsinki, and ethical approval was obtained from the Institutional Review Board of Xuanwu Hospital, Capital Medical University. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}